Opposition 91304695
PendingUSPTO
Opposition 91304695 at USPTO between Alcon Inc. and ACON Pharmaceuticals Inc., over the mark ACON, filed Jan 26, 2026. Status in the office record: pending.
- Status
- Pending
- Filed
- Jan 26, 2026
- Marks involved
- 17
Parties
Who is involved
The parties as named in the office record.
Respondent
ACON Pharmaceuticals Inc.
Timeline
How the case has moved
Dates from the USPTO record and the ACON filing.
ACON filed
Application 98834501 filed at the USPTO.Opposition filed
Alcon Inc. started opposition 91304695 at USPTO against ACON.- Next
Awaiting decision
No decision is recorded at USPTO yet.
Marks
Marks involved
1 contested mark, 16 marks the challenger relies on.
| Mark | Role | Application | Office |
|---|---|---|---|
| ACON | Contested | 98834501 | USPTO |
| ALCON | Relied on | 71607468 | USPTO |
| ALCON | Relied on | 73078918 | USPTO |
| ALCON | Relied on | 73709732 | USPTO |
| ALCON | Relied on | 74116783 | USPTO |
| ALCON | Relied on | 85025114 | USPTO |
| ALCON | Relied on | 85025183 | USPTO |
| ALCON | Relied on | 85025187 | USPTO |
| ALCON | Relied on | 85521528 | USPTO |
| ALCON | Relied on | 85693927 | USPTO |
| ALCON | Relied on | 85693950 | USPTO |
| AUTHORIZED ALCON RETAILER | Relied on | 87051320 | USPTO |
+5 more marks in this case
API
Get this data via the API
Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.
GET/v1/proceedings/{id}Parties, dates, outcome and every mark in the case
GET/v1/proceedings?trademark_id={trademark_id}Every proceeding on a mark
GET /v1/proceedings/{id}
ID=prc_10026fc9-abea-49a6-a4ee-b982a8f66203
curl https://api.signa.so/v1/proceedings/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"id": "prc_10026fc9-abea-49a6-a4ee-b982a8f66203",
"object": "proceeding",
"proceeding_type": "opposition",
"proceeding_number": "91304695",
"status": "pending",
"office_code": "US",
"filed_date": "2026-01-26",
"parties": [
{
"name": "Alcon Inc.",
"role": "opponent"
},
{
"name": "ACON Pharmaceuticals Inc.",
"role": "respondent"
}
]
}